121TiP Prospective, single arm, phase II clinical trial of pembrolizumab combined with neoadjuvant chemoradiotherapy and surgery for locally advanced upper esophageal squamous cell carcinoma. (December 2022) - Qi, L.; Wang, X.; Wang, Z.; Liu, W.; Li, F.; Zhang, X.; He, J.; Li, Y.